|
| Home : Orexo Signs Partnership Agreement With GAIA to Develop and Commercialize a new Digital Therapy for the Treatment of Opioid Use Disorder |
|
Aug 20
2019 |
Orexo Signs Partnership Agreement With GAIA to Develop and Commercialize a new Digital Therapy for the Treatment of Opioid Use Disorder |
|
UPPSALA, Sweden, Aug. 20, 2019 /PRNewswire/ -- Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces it has entered into an exclusive agreement with GAIA AG (GAIA), a global leader in digital therapeutics that... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/orexo-signs-partnership-agreement-with-gaia-to-develop-and-commercialize-a-new-digital-therapy-for-the-treatment-of-opioid-use-disorder-300904149.html |
| |
|
Related News
|
» Nordic Nanovector Appoints Dr Lars Nieba as Chief Technology Officer
» ConXtech, Inc. Announces CTO and Chairman Transition
|
|
|
